Ukulinganiswa kwe-FACECA CRACRETINTINT ithathwa njengophawu oluthembekileyo lokuvuvukala kunye nezifundo ezininzi kubonisa ukuba xa ugxininiso lwe-Faekical Calprotectin luphakanyisiwe kwizigulana nge-IBD, izigulana ezinesifo se-IBS azinawo amanqanaba e-IBD akanawo amanqanaba e-IBD. Amanqanaba anjalo ayandiswa ukuba alungelelanise kakuhle kunye novavanyo lwe-endoscopic kunye novavanyo lwe-gostological yento eyenziwayo.

Iziko le-NHS lokuthenga ngobungqina sele liqhube uphononongo oluninzi kuvavanyo lwezolo kunye nokusetyenziswa kwayo kwi-Ibs eyodwa kunye ne-IBD. Ezi ngxelo zigqibe kwelokuba isebenzisa i-clirprotectin ixhasa ukuphuculwa kolawulo lwesigulana kwaye ibonelela ngemali eninzi yeendleko.

I-FAECAL CRATPRETTTIN isetyenziselwa ukunceda ukwahlula phakathi kwe-Ibs kunye ne-IBD. Ikwasetyenziselwa ukuvavanya ukusebenza kakuhle konyango kwaye kuxele umngcipheko wokuphononongwa kwizigulana ze-Ibd.

Abantwana bahlala benamanqanaba aphezulu kancinane aphezulu kunabantu abadala.

Ke kufuneka ukuba wenze i-cal yokufumanisa kwangaphambili.